Unidad de Investigación y Desarrollo en Alimentos (UNIDA), Tecnológico Nacional de México/Instituto Tecnológico de Veracruz, M.A. de Quevedo 2779, Col. Formando Hogar, Veracruz, Veracruz, México, 91897.
Centro de Investigación en Alimentación y Desarrollo, A.C. (CIAD, A.C.) Carretera Gustavo Enrique Astiazarán Rosas No. 46. Col. La Victoria, Hermosillo, Sonora, México, 83304.
J Dairy Sci. 2021 Apr;104(4):3779-3788. doi: 10.3168/jds.2020-19466.
Hypertension is a risk factor for the development of other cardiovascular diseases and remains one of the leading causes of death worldwide. Although genetic and environmental factors are associated with the development of hypertension, it has been recently recognized that gut microbiota (GM) may also have an effect on human health. In this sense, gut dysbiosis (a marked decrease in richness and diversity of GM) has been linked to different metabolic diseases, such as hypertension. Therefore, different studies have been pursued to reduce gut dysbiosis and diminish hypertension. Different strategies to maintain a balanced GM, particularly through diet and the use of probiotics, are being evaluated. Most recently, the effect of antihypertensive fermented milks on GM has been addressed. New evidence suggests that antihypertensive fermented milks may modulate GM. Thus, the aim of this review is to present available information related to the effect of antihypertensive fermented milks on gut microbiota.
高血压是其他心血管疾病发展的一个风险因素,仍然是全球范围内主要的死亡原因之一。尽管遗传和环境因素与高血压的发展有关,但最近人们已经认识到,肠道微生物群(GM)也可能对人类健康产生影响。从这个意义上说,肠道菌群失调(GM 的丰富度和多样性明显减少)与不同的代谢疾病有关,如高血压。因此,人们已经进行了不同的研究来减少肠道菌群失调和降低高血压。目前正在评估通过饮食和使用益生菌等不同策略来维持 GM 平衡。最近,人们关注了降压发酵乳对 GM 的影响。新的证据表明,降压发酵乳可能会调节 GM。因此,本综述的目的是介绍有关降压发酵乳对肠道微生物群影响的现有信息。